Research.Education.Discovery Blog

The Research.Education.Discovery blog showcases Canadian Blood Services’ work and explains the basic science behind what we do. We invite readers to explore the worlds of transfusion and transplantation science and learn more about how our research leads to improvements in everyday practices and ultimately – and most importantly – better outcomes for patients.

These R.E.D. blog posts are republished from Canadian Blood Services’ main website. See all blogs at blood.ca/RED.

 

April 15, 2021
Guest Author
As this Centre for Blood Research profile highlights, the Centre for Innovation’s Dr. Peter Schubert keeps busy with his various roles at Canadian Blood Services and the University of British Columbia
April 9, 2021
Guest Author
Our research is improving patient safety for those who need intravenous immune globulin (IVIg), a drug used to treat autoimmune diseases. By increasing our understanding of an unexpected, potentially
April 6, 2021
Dr. Geraldine Walsh
The Canadian Blood Services Lifetime Achievement Award recognizes individuals whose landmark contributions are both extraordinary and world class in the field of transfusion or transplantation
March 26, 2021
Tricia Abe
People with a low platelet blood count, such as cancer patients receiving chemotherapy, can receive a platelet transfusion to boost their platelet count. But what is the best approach to platelet
March 11, 2021
Dr. Geraldine Walsh
The Centre for Innovation is delighted to announce the winners of the 2020-2021 Canadian Blood Services Lay Science Writing Competition. Read on to find out who won!
March 4, 2021
Dr. Geraldine Walsh
You may be aware that there’s no deferral for blood donors after they receive a vaccine against COVID-19. But you might be wondering how the blood operators made this decision. Canadian Blood Services
February 23, 2021
Renee Horton
For the 200 Nova Scotians waiting for a lifesaving organ or tissue transplant, new legislation offers hope.
February 18, 2021
Amie T. Kron
A study conducted by researchers in the University of Toronto QUEST program, a research collaborative supported by Canadian Blood Services, looked at what can be done to reduce the number of
February 9, 2021
Tricia Abe
With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral